Meta-analysis of Pancreaticojejunostomy Versus Pancreaticogastrostomy Reconstruction After Pancreaticoduodenectomy.
From: Department of Surgery, University of Calgary, Calgary, Canada.
The British journal of surgery
- Publish Date: Aug 2006
- ISSN: 0007-1323
- Volume: 93
- Issue: 8
- Pages: 929-36
- Medium: Print
- Language: English
- Citation (JAMA): McKay A, Mackenzie S, Sutherland F R, et al. Meta-analysis of Pancreaticojejunostomy Versus Pancreaticogastrostomy Reconstruction After Pancreaticoduodenectomy.. Aug 2006;93:929-36
Abstract
BACKGROUND: Pancreaticoduodenectomy is the primary treatment for periampullary cancer. Associated morbidity is high and often related to pancreatic anastomotic failure. This paper compares rates of pancreatic fistula, morbidity and mortality after pancreaticoduodenectomy in patients having reconstruction by pancreaticogastrostomy with those in patients having reconstruction by pancreaticojejunostomy. METHODS: A meta-analysis was performed of all large cohort and randomized controlled trials carried out since 1990. RESULTS: Eleven articles were identified for inclusion: one prospective randomized trial, two non-randomized prospective trials and eight observational cohort studies. The meta-analysis revealed a higher rate of pancreatic fistula associated with pancreaticojejunostomy reconstruction (relative risk (RR) 2.62 (95 per cent confidence interval (c.i.) 1.91 to 3.60)). A higher overall morbidity rate was also demonstrated in this group (RR 1.43 (95 per cent c.i. 1.26 to 1.61)), as was a higher mortality rate (RR 2.51 (95 per cent c.i. 1.61 to 3.91)). CONCLUSION: Current literature suggests that the safer means of pancreatic reconstruction after pancreaticoduodenectomy is pancreaticogastrostomy, but much of the evidence comes from observational cohort study data.
Mesh Headings (Keywords): Ampulla of Vater, Cohort Studies, Common Bile Duct Neoplasms, Gastrostomy, Humans, Pancreatectomy, Pancreatic Fistula, Pancreaticoduodenectomy, Pancreaticojejunostomy, Prospective Studies, Randomized Controlled Trials as Topic, Risk Factors
Check for Full Text / PubMed Unique Identifier (PMID): 16845693
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.